News on research grants, RFPs, government funding trends in genetics, genomics, and molecular diagnostics.
The team said it will partner with startup Early Diagnostics to commercialize the assay, which integrates DNA methylation analysis and computational technology.
DiaCarta scientists will partner with the University of Florida Health Cancer Center to analyze blood samples from up to 500 cancer patients undergoing radiotherapy.
The technology uses a conducting polymer-based electrochemical chip with an array of electrodes and employs an electrical field to release and detect mutations.
The firm will use the funding to develop and validate an expanded version of its somatic cancer hotspot and monitoring assays.
The company said the NIH funding will enable it to further validate the saliva-based test and prepare it for commercial launch later this year.
